Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-02 Sale | 2026-09-04 4:09 pm | Addex Therapeutics Ltd. | ADXN | Kalinichev Mikhail HEAD OF TRANSLATIONAL SCIENCE | 306,765 | $0 | $0 | 506,765 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:06 pm | Addex Therapeutics Ltd. | ADXN | Nunn Jason Raleigh Director | 219,561 | $0 | $0 | 269,561 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:05 pm | Addex Therapeutics Ltd. | ADXN | Mills Roger CHIEF MEDICAL OFFICER | 392,837 | $0 | $0 | 835,976 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:03 pm | Addex Therapeutics Ltd. | ADXN | Manke Isaac Director | 219,561 | $0 | $0 | 269,561 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:02 pm | Addex Therapeutics Ltd. | ADXN | Lawton Vincent Michael Director | 2,507,487 | $0 | $0 | 3,009,585 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:01 pm | Addex Therapeutics Ltd. | ADXN | Hill Raymond George Director | 1,365,532 | $0 | $0 | 1,638,639 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:00 pm | Addex Therapeutics Ltd. | ADXN | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | 16,413,787 | $0 | $0 | 20,218,775 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-02 Option Award | 2026-09-04 4:11 pm | 2018-01-08 2027-12-31 | Addex Therapeutics Ltd. | ADXN | Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER | 602,908 | $0 | 9,043,620 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:09 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Kalinichev Mikhail HEAD OF TRANSLATIONAL SCIENCE | 506,765 | $0 | 506,765 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:06 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Nunn Jason Raleigh Director | 269,561 | $0 | 269,561 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:05 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Mills Roger CHIEF MEDICAL OFFICER | 442,837 | $0 | 835,976 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:03 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Manke Isaac Director | 269,561 | $0 | 269,561 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:02 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Lawton Vincent Michael Director | 3,009,085 | $0 | 3,009,585 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:01 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Hill Raymond George Director | 1,638,639 | $0 | 1,638,639 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 4:00 pm | 2024-01-08 2034-01-07 | Addex Therapeutics Ltd. | ADXN | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | 19,783,583 | $0 | 20,218,775 (Direct) | View |
Ownership | 2026-03-25 4:03 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Mills Roger CHIEF MEDICAL OFFICER | 0 | $0 | 835,976 (Direct) | View |
Ownership | 2026-03-25 4:03 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Lawton Vincent Michael Director | 0 | $0 | 3,009,585 (Direct) | View |
Ownership | 2026-03-25 4:02 pm | 2018-01-01 2027-12-31 | Addex Therapeutics Ltd. | ADXN | Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER | 0 | $0 | 602,908 (Direct) | View |
Ownership | 2026-03-25 4:01 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Kalinichev Mikhail HEAD OF TRANSLATIONAL SCIENCE | 0 | $0 | 506,765 (Direct) | View |
Ownership | 2026-03-25 4:01 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Hill Raymond George Director | 0 | $0 | 1,638,639 (Direct) | View |
Ownership | 2026-03-18 11:07 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Dyer Timothy Mark Chief Executive Officer 10% Owner | 0 | $0 | 20,218,775 (Direct) | View |
Ownership | 2026-03-18 11:06 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Nunn Jason Raleigh Director | 0 | $0 | 269,561 (Direct) | View |
Ownership | 2026-03-18 11:06 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Manke Isaac Director | 0 | $0 | 269,561 (Direct) | View |